A multicenter trial in Alzheimers disease found no benefit on cognitive or functional outcomes while shifting some biomarkers, a smaller trial in healthy older adults reported improved memory and hippocampal connectivity, and the overall assessment is that it is unlikely to help most healthy adults and that the evidence is not conclusive
This treatment may also be recommended for patients who struggle with persistent weight challenges despite diet and exercise, have metabolic concerns or insulin sensitivity challenges, or are seeking medically supervised weight management with a structured, physician-led plan
Alternative GLP-1 receptor agonists with different pharmacokinetic profiles may be better tolerated in some individuals
Tirzepatide# Tirzepatide is a 39-amino acid peptide with a C20 fatty diacid side chain that activates two receptors: GIP receptor : Tirzepatide shows approximately 5-fold selectivity for GIP over GLP-1 receptors, representing a GIP-dominant dual agonist GLP-1 receptor : Provides complementary glucose-lowering and appetite-suppressing effects The GIP receptor engagement is a key differentiator from pure GLP-1 agonists like semaglutide
The rs6923761 variant is one key genetic marker that influences how effectively your cells respond to semaglutide activation
People shared what helped them, what didnt, and asked others for tips